$LAB
STANDARD BIOTOOLS INC.

2013 Q3 Form 10-Q Financial Statement

#000119312513324552 Filed on August 07, 2013

View on sec.gov

Income Statement

Concept 2013 Q3 2013 Q2 2012 Q2
Revenue $18.29M $17.48M $12.95M
YoY Change 43.07% 35.0% 22.43%
Cost Of Revenue $5.138M $4.876M $3.926M
YoY Change 46.05% 24.2% 32.19%
Gross Profit $13.15M $12.60M $9.022M
YoY Change 41.94% 39.7% 18.55%
Gross Profit Margin 71.9% 72.11% 69.68%
Selling, General & Admin $12.10M $11.60M $9.421M
YoY Change 32.9% 23.1% 20.17%
% of Gross Profit 92.0% 92.01% 104.42%
Research & Development $5.004M $4.997M $3.987M
YoY Change 22.92% 25.33% 16.58%
% of Gross Profit 38.06% 39.65% 44.19%
Depreciation & Amortization $660.0K $610.0K $190.0K
YoY Change 83.33% 221.05% -20.83%
% of Gross Profit 5.02% 4.84% 2.11%
Operating Expenses $17.10M $16.59M $13.41M
YoY Change 29.82% 23.76% 19.08%
Operating Profit -$4.952M -$3.990M -$4.386M
YoY Change 26.68% -9.03% 20.16%
Interest Expense $1.000K $2.000K $202.0K
YoY Change -99.07% -99.01% -139.61%
% of Operating Profit
Other Income/Expense, Net $709.0K -$39.00K $9.000K
YoY Change -1045.33% -533.33% -77.5%
Pretax Income -$4.244M -$4.031M -$4.579M
YoY Change 3.74% -11.97% -35.69%
Income Tax $42.00K $15.00K $1.000K
% Of Pretax Income
Net Earnings -$4.286M -$4.046M -$4.580M
YoY Change 3.23% -11.66% -36.3%
Net Earnings / Revenue -23.44% -23.15% -35.37%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.17 -$0.16 -$0.22
COMMON SHARES
Basic Shares Outstanding 25.50M shares 25.42M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q3 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $63.70M $60.40M $37.90M
YoY Change -26.1% 59.37% -41.15%
Cash & Equivalents $20.10M $32.29M $9.854M
Short-Term Investments $43.60M $28.10M $28.00M
Other Short-Term Assets $2.500M $2.000M $1.600M
YoY Change 66.67% 25.0% 6.67%
Inventory $8.021M $7.233M $6.600M
Prepaid Expenses
Receivables $12.41M $10.84M $9.600M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $86.66M $80.54M $55.70M
YoY Change -17.86% 44.6% -31.23%
LONG-TERM ASSETS
Property, Plant & Equipment $5.155M $4.919M $4.000M
YoY Change 19.88% 22.98% 60.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $19.10M $23.10M $1.000M
YoY Change 496.88% 2210.0% -23.08%
Other Assets $3.288M $3.431M $4.200M
YoY Change -17.8% -18.31% 425.0%
Total Long-Term Assets $27.58M $31.42M $9.200M
YoY Change 137.78% 241.55% 95.74%
TOTAL ASSETS
Total Short-Term Assets $86.66M $80.54M $55.70M
Total Long-Term Assets $27.58M $31.42M $9.200M
Total Assets $114.2M $112.0M $64.90M
YoY Change -2.44% 72.52% -24.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.406M $1.997M $3.300M
YoY Change 3.21% -39.48% 10.0%
Accrued Expenses $5.117M $4.641M $5.000M
YoY Change -11.78% -7.18% 6.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $1.900M
YoY Change -100.0% -100.0%
Long-Term Debt Due $2.800M
YoY Change -66.27%
Total Short-Term Liabilities $15.04M $11.63M $14.80M
YoY Change 14.83% -21.45% -16.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $362.0K $310.0K $1.200M
YoY Change -72.15% -74.17% 33.33%
Total Long-Term Liabilities $362.0K $310.0K $1.200M
YoY Change -72.15% -74.17% -78.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.04M $11.63M $14.80M
Total Long-Term Liabilities $362.0K $310.0K $1.200M
Total Liabilities $17.23M $13.58M $16.00M
YoY Change 19.65% -15.13% -31.62%
SHAREHOLDERS EQUITY
Retained Earnings -$252.7M -$248.4M
YoY Change
Common Stock $26.00K $25.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $97.01M $98.39M $48.90M
YoY Change
Total Liabilities & Shareholders Equity $114.2M $112.0M $64.90M
YoY Change -2.44% 72.52% -24.27%

Cashflow Statement

Concept 2013 Q3 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income -$4.286M -$4.046M -$4.580M
YoY Change 3.23% -11.66% -36.3%
Depreciation, Depletion And Amortization $660.0K $610.0K $190.0K
YoY Change 83.33% 221.05% -20.83%
Cash From Operating Activities -$1.310M -$2.640M -$4.000M
YoY Change -60.78% -34.0% -65.75%
INVESTING ACTIVITIES
Capital Expenditures $550.0K $1.360M $840.0K
YoY Change 44.74% 61.9% 71.43%
Acquisitions
YoY Change
Other Investing Activities -$11.51M -$26.15M $7.430M
YoY Change -303.0% -451.95% -122.95%
Cash From Investing Activities -$12.06M -$27.52M $6.590M
YoY Change -328.41% -517.6% -120.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.080M 650.0K -1.130M
YoY Change -98.0% -157.52% -6.61%
NET CHANGE
Cash From Operating Activities -1.310M -2.640M -4.000M
Cash From Investing Activities -12.06M -27.52M 6.590M
Cash From Financing Activities 1.080M 650.0K -1.130M
Net Change In Cash -12.29M -29.51M 1.460M
YoY Change -121.92% -2121.23% -103.19%
FREE CASH FLOW
Cash From Operating Activities -$1.310M -$2.640M -$4.000M
Capital Expenditures $550.0K $1.360M $840.0K
Free Cash Flow -$1.860M -$4.000M -$4.840M
YoY Change -50.0% -17.36% -60.23%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1543000
CY2013Q2 us-gaap Liabilities
Liabilities
13580000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1510000
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
25000
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25496239 shares
CY2013Q1 fldm Expected Milestone Receivable
ExpectedMilestoneReceivable
3200000
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9854000
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25479000 shares
CY2013Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25479000 shares
CY2013Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1644000
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11626000
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-795000
CY2013Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2771000
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
347573000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9821000
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1997000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
399000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1523000
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
310000
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
98385000
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-248418000
CY2013Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2217000
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4641000
CY2013Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1169000
CY2013Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
385000
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
111965000
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3431000
CY2013Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
16407000
CY2013Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10839000
CY2013Q2 us-gaap Inventory Net
InventoryNet
7233000
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
3245000
CY2013Q2 us-gaap Cash
Cash
14977000
CY2013Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2549000
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4919000
CY2013Q2 us-gaap Assets
Assets
111965000
CY2013Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
68522000
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32290000
CY2013Q2 us-gaap Short Term Investments
ShortTermInvestments
28136000
CY2013Q2 us-gaap Loss Contingency Range Of Possible Loss Maximum
LossContingencyRangeOfPossibleLossMaximum
1000000
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1439000
CY2013Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
18500000
CY2013Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
906000
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2044000
CY2013Q2 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
29000000
CY2013Q2 us-gaap Long Term Investments
LongTermInvestments
23073000
CY2013Q2 us-gaap Assets Current
AssetsCurrent
80542000
CY2013Q2 fldm Operating Leases Future Minimum Payments Due After Five Years And Thereafter
OperatingLeasesFutureMinimumPaymentsDueAfterFiveYearsAndThereafter
3677000
CY2010Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
7000000
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13553000
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25115000 shares
CY2012Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25115000 shares
CY2012Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1241000
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11597000
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-769000
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2877000
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
342222000
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2555000
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
237000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
100657000
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-240821000
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4279000
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
448000
CY2012Q4 us-gaap Liabilities
Liabilities
13075000
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
25000
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
113732000
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3881000
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1886000
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2012Q4 us-gaap Cost Method Investments
CostMethodInvestments
1300000
CY2012Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
17000
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12900000
CY2012Q4 us-gaap Inventory Net
InventoryNet
7169000
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2954000
CY2012Q4 us-gaap Cash
Cash
57082000
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2846000
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4974000
CY2012Q4 us-gaap Assets
Assets
113732000
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
26596000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58649000
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
21362000
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1369000
CY2012Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1550000
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1131000
CY2012Q4 us-gaap Long Term Investments
LongTermInvestments
3666000
CY2012Q4 us-gaap Assets Current
AssetsCurrent
101211000
dei Trading Symbol
TradingSymbol
FLDM
dei Entity Registrant Name
EntityRegistrantName
FLUIDIGM CORP
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Entity Central Index Key
EntityCentralIndexKey
0001162194
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25343000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3521000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Reclassifications</b></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">Certain items previously reported in the condensed consolidated statement of cash flows have been reclassified to conform to the current period presentation. Such reclassifications do not impact previously reported net cash used in operating activities, net cash provided by investing activities, net cash used in financing activities, or the net decrease in cash and cash equivalents.</font></p> </div>
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11230000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1211000 shares
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Segment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
912000
us-gaap Licenses Revenue
LicensesRevenue
163000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
31522000
us-gaap Stock Granted During Period Value Sharebased Compensation Gross
StockGrantedDuringPeriodValueSharebasedCompensationGross
11200000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-252000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
40620000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7544000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2143000
us-gaap Revenues
Revenues
32015000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
958000
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1777000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7623000
us-gaap Revenue From Grants
RevenueFromGrants
330000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-29000
us-gaap Operating Income Loss
OperatingIncomeLoss
-9057000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1148000
us-gaap Net Income Loss
NetIncomeLoss
-7597000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
433000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-26000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
14440000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
9135000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1193000
us-gaap Costs And Expenses
CostsAndExpenses
41072000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2420000
us-gaap Share Based Compensation
ShareBasedCompensation
2932000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26359000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
22743000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-135000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
882000
us-gaap Interest Expense
InterestExpense
12000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-116000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
181000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2420000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2900000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25123000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9194000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3117000
fldm Date Of Reincorporation Of Company
DateOfReincorporationOfCompany
2007-07
fldm Date Of Incorporation Of Company
DateOfIncorporationOfCompany
1999-05
fldm Transaction Costs
TransactionCosts
200000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20469000 shares
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10643000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.55
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1239000
us-gaap Licenses Revenue
LicensesRevenue
38000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
23524000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-52000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7353000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
22365000
us-gaap Revenues
Revenues
23893000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
258000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
348000
us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11298000
us-gaap Revenue From Grants
RevenueFromGrants
331000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-25000
us-gaap Operating Income Loss
OperatingIncomeLoss
-10669000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Net Income Loss
NetIncomeLoss
-11270000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
876000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-28000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
34760000
us-gaap Cost Of Goods Sold
CostOfGoodsSold
7472000
us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
1059000
us-gaap Costs And Expenses
CostsAndExpenses
34562000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4172000
us-gaap Share Based Compensation
ShareBasedCompensation
2014000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3699000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18824000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
40000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-40000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2000
us-gaap Interest Expense
InterestExpense
509000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-722000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-265000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1306000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1875000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11156000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8266000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
0
CY2012Q2 fldm Debt Instrument Additional Payment Principal
DebtInstrumentAdditionalPaymentPrincipal
1900000
CY2011Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
600000
CY2012Q1 fldm Debt Instrument Additional Payment Principal
DebtInstrumentAdditionalPaymentPrincipal
2300000
CY2013Q1 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
1800000
CY2013Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3100000
CY2013Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1000000
CY2010Q4 us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Two-year bank line of credit agreement (as amended, the Line of Credit) that provided us with the ability to borrow up to $7.0 million, subject to certain covenants and other restrictions, and bore interest at a rate equal to the greater of (i) 4.25% or (ii) the prime rate plus 1.00% per year.
CY2010Q4 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0100 pure
CY2010Q4 us-gaap Line Of Credit Facility Interest Rate During Period
LineOfCreditFacilityInterestRateDuringPeriod
0.0425 pure
CY2010Q4 fldm Term Of Contractual Agreement Include Line Of Credit Facility
TermOfContractualAgreementIncludeLineOfCreditFacility
P2Y
CY2012 fldm Line Of Credit Facility Extension Length
LineOfCreditFacilityExtensionLength
P2Y
CY2012Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
20544000 shares
CY2012Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
12768000
CY2012Q2 us-gaap Licenses Revenue
LicensesRevenue
15000
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4579000
CY2012Q2 us-gaap Revenues
Revenues
12948000
CY2012Q2 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4584000
CY2012Q2 us-gaap Revenue From Grants
RevenueFromGrants
165000
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4386000
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
-4580000
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
3926000
CY2012Q2 us-gaap Costs And Expenses
CostsAndExpenses
17334000
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9421000
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000
CY2012Q2 us-gaap Interest Expense
InterestExpense
202000
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1100000
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3987000
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
25443000 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
118000 shares
CY2013Q2 us-gaap Licenses Revenue
LicensesRevenue
48000
CY2013Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
17267000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-39000
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4031000
CY2013Q2 us-gaap Revenues
Revenues
17480000
CY2013Q2 us-gaap Cost Method Investments Realized Gain Loss
CostMethodInvestmentsRealizedGainLoss
0
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4069000
CY2013Q2 us-gaap Revenue From Grants
RevenueFromGrants
165000
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3990000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-4046000
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23000
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4876000
CY2013Q2 us-gaap Costs And Expenses
CostsAndExpenses
21470000
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11597000
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000
CY2013Q2 us-gaap Interest Expense
InterestExpense
2000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1700000
CY2013Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4997000

Files In Submission

Name View Source Status
0001193125-13-324552-index-headers.html Edgar Link pending
0001193125-13-324552-index.html Edgar Link pending
0001193125-13-324552.txt Edgar Link pending
0001193125-13-324552-xbrl.zip Edgar Link pending
d556920d10q.htm Edgar Link pending
d556920dex311.htm Edgar Link pending
d556920dex312.htm Edgar Link pending
d556920dex321.htm Edgar Link pending
d556920dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
fldm-20130630.xml Edgar Link completed
fldm-20130630.xsd Edgar Link pending
fldm-20130630_cal.xml Edgar Link unprocessable
fldm-20130630_def.xml Edgar Link unprocessable
fldm-20130630_lab.xml Edgar Link unprocessable
fldm-20130630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending